Overview
The Union Government has officially enforced a ban on the manufacture and sale of oral formulations of Nimesulide exceeding 100 mg. The decision was taken due to growing safety concerns regarding liver toxicity associated with high doses.
Regulation Details
- Limit: Only formulations up to 100 mg are permitted
- Reason: Risk of hepatotoxicity (liver damage) at higher concentrations
- Public Health: Aims to safeguard patients from adverse drug reactions
- Compliance: Pharmacies and manufacturers must withdraw non-compliant stocks immediately